Search by Drug Name or NDC
NDC 71671-0100-03 Twirla 2.3; 2.6 mg/1; mg/1 Details
Twirla 2.3; 2.6 mg/1; mg/1
Twirla is a TRANSDERMAL PATCH in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Agile Therapeutics, Inc.. The primary component is ETHINYL ESTRADIOL; LEVONORGESTREL.
Product Information
| NDC | 71671-0100 |
|---|---|
| Product ID | 71671-100_f70170ed-1a88-45e8-9ca4-50f203ac8420 |
| Associated GPIs | 25960002408820 |
| GCN Sequence Number | 080745 |
| GCN Sequence Number Description | levonorgestrel/ethin.estradiol PATCH TDWK 120-30/24H TRANSDERM |
| HIC3 | G8F |
| HIC3 Description | CONTRACEPTIVES,TRANSDERMAL |
| GCN | 47708 |
| HICL Sequence Number | 001460 |
| HICL Sequence Number Description | LEVONORGESTREL/ETHINYL ESTRADIOL |
| Brand/Generic | Brand |
| Proprietary Name | Twirla |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | levonorgestrel/ethinyl estradiol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | PATCH |
| Route | TRANSDERMAL |
| Active Ingredient Strength | 2.3; 2.6 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ETHINYL ESTRADIOL; LEVONORGESTREL |
| Labeler Name | Agile Therapeutics, Inc. |
| Pharmaceutical Class | Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA204017 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71671-0100-03 (71671010003)
| NDC Package Code | 71671-100-03 |
|---|---|
| Billing NDC | 71671010003 |
| Package | 3 POUCH in 1 CARTON (71671-100-03) / 1 PATCH in 1 POUCH (71671-100-11) |
| Marketing Start Date | 2020-09-11 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 65.1883 |
| Pricing Unit | EA |
| Effective Date | 2023-07-17 |
| NDC Description | TWIRLA 120-30 MCG/DAY PATCH |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis